Novartis urges Britain to secure drug supplies before Brexit

The Swiss company, one of the world’s biggest drugmakers, said the risk of Britain leaving the European Union, its biggest trading partner, without a deal had risen after Prime Minister Theresa May failed to get her deal through parliament last week. “Given the complex nature of the supply chain, government needs to implement a comprehensive continuity plan rapidly,” Novartis said https://www.novartis.co.uk/news/media-releases/novartis-uk-brexit-statement in a statement. Novartis’s fastest-growing medicine is Cosentyx, the blockbuster medicine for psoriasis and other auto-immune disorders including ankylosing spondylitis.